May 2020


Microfluidic drug delivery to tumor slice cultures

Personalized cancer therapy hinges upon predicting which patient is more responsive to specific therapies. It is based on the notion that the patient’s genotypes can affect the metabolism and drug toxicity while the tumor biomarkers are the indicators of the effectiveness of the treatment and...

microfluidic immunoassay chip

Microfluidic platform for screening cardiac disease biomarkers

Rapid and in-time monitoring of disease-specific biomarkers holds a significant value in disease prevention and early treatment. It also is important to monitor these biomarkers post-treatment to make sure of the efficiency of the treatment. A multi-disciplinary team of researchers has recently reported a microfluidic...